Clinical Trial Detail


Missing content? – Request curation!

Request curation for specific Genes, variants, or PubMed publications.

Have questions, comments or suggestions? - Let us know!

Email us at :

NCT ID NCT04205409
Title Nivolumab for the Treatment of Relapsed or Refractory Hematologic Malignancies
Recruitment Recruiting
Gender both
Phase Phase II
Variant Requirements No
Sponsors University of Washington

chronic lymphocytic leukemia

marginal zone B-cell lymphoma

diffuse large B-cell lymphoma

follicular lymphoma

non-Hodgkin lymphoma

multiple myeloma



Age Groups: senior | adult
Covered Countries USA

No variant requirements are available.